• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL AMPLATZER SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL AMPLATZER SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Catalog Number UNK AMPLATZER SEPTAL OCCLUDER
Device Problems Migration or Expulsion of Device (1395); Patient Device Interaction Problem (4001)
Patient Problems Dyspnea (1816); Foreign Body In Patient (2687)
Event Date 09/27/2023
Event Type  Injury  
Event Description
The article, "migration of an atrial septal defect occluder in a pregnant patient", was reviewed.The article presented a case study of a 24-year-old woman at 28 weeks¿ gestation with a medical history of mitral valve prolapse and large ostium secundum atrial septal defect (asd).It was reported that on an unknown date, an unknown amplatzer septal occluder was implanted.It was reported 3 years later on an unknown date, a transthoracic echocardiography (tte) noted the device was well seated with residual shunting.It was then reported 5 years post-procedure on an unknown date, the patient presented with dyspnea with exertion.A tte revealed the measured asd was 26.8mm in diameter but absence of the device.A 2-view chest x-ray revealed the device had embolized into the pulmonary artery and likely endothelialized.Surgical removal was planned but it was reported the patient was lost to follow up after successful delivery with no complications.The article concluded delayed asdo migration is an infrequent and previously unreported complication in a pregnant patient.Transthoracic echocardiogram is a safe, rapid, and noninvasive study during pregnancy that allows asdo localization and hemodynamic evaluation that can help guide decision-making.They reported a conservative approach to an embolized asdo discovered within the pulmonary artery in a hemodynamically stable patient who subsequently underwent uncomplicated delivery.[the primary and corresponding author was rosario colombo, md, department of cardiology, jackson memorial hospital, 1611 nw 12th avenue, miami, florida 33136, with corresponding e-mail: rosario.Colombo@jhsmiami.Org].
 
Manufacturer Narrative
Literature article: migration of an atrial septal defect occluder in a pregnant patient investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Manufacturer Narrative
Summarized patient outcomes/complications of amplatzer septal occluder were reported in a research article in a subject population with medical history of mitral valve prolapse.Some of the complications reported were residual shunting, hospitalization, dyspnea and device embolization; these complications are anticipated for the procedure and subject population.A more comprehensive assessment could not be performed as the event was non-contemporaneously reported through a literature review and no device or individual patient information was received for analysis.Literature attachment: article title: migration of an atrial septal defect occluder in a pregnant patientd1 - brand name, d2a - common device name, d2b - procode, d4 - catalog #.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER SEPTAL OCCLUDER
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ABBOTT MEDICAL REG# 2135147
5050 nathan ln n
plymouth MN 55442
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key18125261
MDR Text Key327998911
Report Number2135147-2023-04997
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P000039
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 12/07/2023
2 Devices were Involved in the Event: 1   2  
1 Patient was Involved in the Event
Date FDA Received11/13/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNK AMPLATZER SEPTAL OCCLUDER
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/14/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age24 YR
Patient SexFemale
-
-